Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT

Clinical trial NCT04746209 · RECRUITING

Trial details

NCT number: NCT04746209
Sponsor: Medical College of Wisconsin
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

B-cell Acute Lymphoblastic Leukemia B-cell Childhood Acute Lymphoblastic Leukemia B-Cell ALL, Childhood

Start date: 2021-02-01
Primary completion: 2024-02-28
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.